Preactive Multiple Sclerosis Lesions Offer Novel Clues for Neuroprotective Therapeutic Strategies

E-ISSN： 1996-3181|10|1|68-81

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.10, Iss.1, 2011-02, pp. : 68-81

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Approaches to neuroprotective strategies in multiple sclerosis

By Tselis Alex Khan Omar A Lisak Robert P

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 17, 2010-12 ,pp. : 2869-2878

Informa Healthcare

Access to resources Recommend Favorite

Novel therapeutic agents for multiple sclerosis

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 12, 1999-12 ,pp. : 1739-1741

Informa Healthcare

Access to resources Recommend Favorite

Remyelinating and neuroprotective treatments in multiple sclerosis

By Stangel Martin

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 4, 2004-04 ,pp. : 331-347

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic Strategies To Prevent Neurodegeneration And Promote Regeneration In Multiple Sclerosis

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 5, Iss. 1, 2005-01 ,pp. : 11-26

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic developments in multiple sclerosis

By Goodin D.S.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 4, 2000-04 ,pp. : 655-670

Informa Healthcare

Access to resources Recommend Favorite